Similar Efficacy for Key Anti-VEGF Agents in Macular Edema Similar Efficacy for Key Anti-VEGF Agents in Macular Edema

The SCORE2 trial shows that bevacizumab and aflibercept may produce similar short-term outcomes. Here is a closer look at its results.Medscape Optometry

Source: Medscape Today Headlines - June 20, 2017 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news